In vivo experimental approach to treatment against tabun poisoning

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 25, Issue 4, 2010, Pages 531-536

  Berend, Suzana ^a   Katalinić, Maja ^a   Luci Vrdoljak, Ana ^a   Kovarik, Zrinka ^a   Kuča, Kamil ^b,c   Radi, Božica ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Atropine; Mice; Oxime; Pretreatment; Pyridostigmine; Tabun

Indexed keywords

(1(4 HYDROXYIMINOMETHYLPYRIDINIUM) 4 (4 CARBAMOYLPYRIDINIUM)BUTANE DIBROMIDE); (1,3 BIS(4 HYDROXYIMINOMETHYLPYRIDINIUM)BUTANE DIBROMIDE); ATROPINE; K 048; K 074; OXIME DERIVATIVE; PYRIDOSTIGMINE; TABUN; TRIMEDOXIME; UNCLASSIFIED DRUG; 1,4-BIS(4-HYDROXYIMINOMETHYLPYRIDINIUM)BUTANE DIBROMIDE; 1-(4-HYDROXYIMINOMETHYLPYRIDINIUM)-4-(4-CARBAMOYLPYRIDINIUM)BUTANE; BUTANE; CHEMICAL WARFARE AGENT; CHOLINESTERASE INHIBITOR; ORGANOPHOSPHATE; OXIME; PROTECTIVE AGENT; PYRIDINIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG STRUCTURE; EXPERIMENTAL STUDY; GAS POISONING; IN VIVO STUDY; LD 50; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TABUN POISONING; ANIMAL; COMPARATIVE STUDY; EVALUATION STUDY; ORGANOPHOSPHATE POISONING; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALIA; MUS;

ANIMALS; ATROPINE; BUTANES; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; MICE; ORGANOPHOSPHATE POISONING; ORGANOPHOSPHATES; OXIMES; PROTECTIVE AGENTS; PYRIDINIUM COMPOUNDS; SURVIVAL RATE; TREATMENT OUTCOME; TRIMEDOXIME;

EID: 77954395551     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756360903357593     Document Type: Article

References (44)

1. Macilwain C. Study proves Iraq used nerve gas. Nature 1993;363:3.
2. Nagao M, Takatori T, Matsuda Y, Nakajima M, Iwase H, Iwadate K. Defnitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol Appl Pharmacol 1997;144:198-203. (Pubitemid 27208353)
3. Taylor P. Anticholinesterase agents. In: Hardman LELJG, Gilman AG, eds. Te Pharmacological Basis of Terapeutics. New York: McGraw-Hill, 2001:175-197
4. Moore DH, Saunders-Price BB. Pharmaceutical countermeasures to chemical warfare agents. ASA Newslett 2, 2005;1:27-9; http://www.asanltr. com/newsletter/05-2/articles/052c.htm.
5. Eto M. Organophosphorus Pesticides: Organic and Biological Chemistry. Cleveland, OH: CRC Press, 1976:142.
6. Maksimovic M, Bo kovic B, Radovic L, Tadic V Deljac V Binenfeld Z. Antidotal efects of bis-pyridinium-2-monooxime carbonyl derivatives in intoxications with highly toxic organophosphorus compounds. Acta Pharm Jugoslav 1980;30:151-160 (Pubitemid 11163537)
7. Dawson RM. Review of oximes available for the treatment of nerve agent poisoning. J Appl Toxicol 1994;14:317-331
8. Jokanovic M, Maksimovic M, Kilibarda V Jovanovic D, Savic D. Oxime-induced reactivation of acetylcholinesterase inhibited by phosphorami-dates. Toxicol Lett 1996;85:35-39 (Pubitemid 26119687)
9. Clement JG, Shilof JD, Gennings C. Efcacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime against tabun and soman poisoning of mice. Arch Toxicol 1987;61:70-75 (Pubitemid 17149979)
10. Tiermann H, Szinicz L, Eyer P, Felgenhauer N, Zilker T, Worek F. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning. Toxicology 2007;233:145-154 (Pubitemid 46498387)
11. Reiner E. Inhibition of acetylcholinesterase by 4,4'-bipyridine and its efect upon phosphylation of the enzyme. Croat Chem Acta 1986;59:925-931
12. Simeon-Rudolf V Reiner E, Škrinjaric-Špoljar M, Radic B, Lucie A, Primo ic I, et al. Quinuclidinium-imidazolium compounds: synthesis, mode of interaction with acetylcholinesterase and efect upon soman intoxicated mice. Arch Toxicol 1998;72:289-295 (Pubitemid 28204255)
13. Calic M, Lucic Vrdoljak A, Radic B, Jelic D, Jun D, Kuca K, et al. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, efect on tabun-and soman-poisoned mice and their cytotoxicity. Toxicology 2006;219:85-96. (Pubitemid 43120709)
14. Lucie Vrdoljak A, Calic M, Radic B, Berend S, Jun D, Kuca K, et al. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Toxicology 2006;228:41-50. (Pubitemid 44548101)
15. Berend S, Lucic Vrdoljak A, Radic B, Kuca K. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efcency in soman and tabun poisoning. Chem Biol Interact 2008;175:413-416
16. Kovarik Z, Calic M, Šinko G, Bosak A, Berend S, Lucie Vrdoljak A, et al. Oximes: reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. Chem Biol Interact 2008;175:173-179
17. Kovarik Z, Lucie Vrdoljak A, Berend S, Calic M, Kuca K, Musilek K, et al. Evaluation of oxime K203 as antidote in tabun poisoning. Arh Hig Rada Toksikol 2009; 60:19-25.
18. Anderson DR, Harris LW, Woodard CL, Lennox WI. Te efect of pyridostigmine pretreatment on oxime efcacy against intoxication by soman or VX in rats. Drug Chem Toxicol 1992;15:285-292
19. Kassa J, Vachek J. A comparison of the efcacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice. Toxicology 2002;177:179-185 (Pubitemid 34804305)
20. Vachek J, Kassa J, Fusek J, Bajgar J. Te present possibilities of the treatment of poisonings with organophosphates. Sbor ved Prací VLA JEP Hradec Králové 1993;116:67-95.
21. Bajgar J. Prophylaxis against organophosphorus poisoning. J Med Chem Def 2003;1:1-19.
22. Kuca K, Bielavsky J, Cabal J, Kassa J. Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg Med Chem Lett 2003;13:3545-3547 (Pubitemid 37141426)
23. Kuca K, Cabal J, Musilek K, Jun D, Bajgar J. Efective bisquaternary reactivators of tabun-inhibited AChE. J Appl Toxicol 2005;25;491-495 (Pubitemid 43045666)
24. Tompson WR. Use of moving averages and interpolation to estimate median-efective dose. Bacteriol Rev 1947;11:115-145
25. 50) and instruction in their use. Biometrics 1952;8:249-263
26. Ohtomi S, Takase S, Kumagai F. Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital. Int Rev Armed Serv 1996;69:97-102.
27. Harris LW, McDonough JH Jr, Stitcher DL, Lennox WJ. Protection against both lethal and behavioural efects of soman. Drug Chem Toxicol 1984;7:605-624
28. Harris LW, Heyl WC, Stitcher DL, Broomfeld CA. Efects of 1,1'-oxydimethylene bis-(4-tert-butylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman-and sarin-inhibited cholinesterase by oximes. Biochem Pharmacol 1978;27:757-761
29. Škrinjaric-Špoljar M, Burger N, Lovric J. Inhibition of acetylcholinesterase by three new pyridinium compounds and their efect on phosphonylation of the enzyme. J Enzym Inhib 1999;14:331-341
30. Lallement G, Baille V, Baubichon D, Carpentier P, Collombet JM, Filliat P, et al. Review of the value of huperzine as pretreatment of organophos-phate poisoning. Neurotoxicology 2002;23:1-5. (Pubitemid 36559693)
31. Eckert S, Eyer P, Muckter H, Worek F. Kinetic analysis of the protection aforded by reversible inhibitors against irreversible inhibition of acetyl-cholinesterase by highly toxic organophosphorus compounds. Biochem Pharmacol 2006;72:344-357 (Pubitemid 43975078)
32. Dunn MA, Hackley BE, Sidell FR. Pretreatment for nerve agent exposure. In: Sidell FR, Takafuji ET, Franz DR, eds. Medical Aspects of Chemical Biological Warfare. Washington, DC: Walter Reed Army Medical Center, 1997: 181-196
33. Lenz DE, Broomfield CA, Maxwell DM, Cerasoli DM. Nerve agent bio-scavengers: protection against high-and low-dose organophospho-rus exposure. In: Somani SM, Romano JA Jr, eds. Chemical Warfare Agents: Toxicity at Low Levels. Boca Raton, FL: CRC Press, 2001: 215-243
34. Doctor BP, Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interact 2005;157-8:167-171 (Pubitemid 41757647)
35. Saxena A, Sun W, Luo C, Doctor BP. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice. Chem Biol Interact 2005;157-8:199-203. (Pubitemid 41757651)
36. Puu G, Artursson E, Bucht G. Reactivation of nerve agent inhibited acetylcholinesterase by HI-6 and obidoxime. Biochem Pharmacol 1986;35:1505-1510 (Pubitemid 16038005)
37. Antonijevic B, Bokonjic D, Stojiljkovic MP, Kilibarda V, Milovanovic ZA, Nedeljkovic M, et al. Efcacy of trimedoxime in mice poisoned with dichlorvos, heptenophos or monocrotophos. Basic Clin Pharmacol Toxicol 2005;96:111-117 (Pubitemid 40320614)
38. Shih TM, Koviak TA, Capacio BR. Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci Biobehav Rev 1991;15:349-362
39. Shih TM, McDonough JH, Koplovitz I. Anticonvulsants for soman-induced seizure activity. J Biomed Sci 1999;6:86-96. (Pubitemid 29148224)
40. Petroianu GA, Hasan MY, Nurulain SM, Shafullah M, Sheen R, Nagelkerke N. Ranitidine in acute high-dose organophosphate exposure in rats: efect of the time-point of administration and comparison with pyridostigmine. Basic Clin Pharmacol Toxicol 2006;99:312-316 (Pubitemid 44578908)
41. Thiermann H, Szinicz L, Eyer P, Felgenhauer N, Zilker T, Worek F. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning. Toxicology 2007;233:145-154 (Pubitemid 46498387)
42. Kuca K, Barto ová L, Jun D, Patocka J, Cabal J, Kassa J, et al. New quaternary pyridine aldoximes as causal antidotes against nerve agents intoxications. Biomed Papers 2005;149:75-82.
43. Golomb BA, Anthony CR. A review of the scientifc literature as it pertains to Gulf War ilness: pyridostigmine bromide. RAND Health Testimony. Santa Monica, CA: RAND Health, 1999.
44. Koplovitz I, Harris LW, Anderson DR, Lennox WJ, Stewart JR. Reduction by pyridostigmine pretreatment of the efcacy of atropine and 2-PAM treatment of sarin and VX poisoning in rodents. Fundam Appl Toxicol 1992;18:102-106